Navigation Links
Clearview Treatment Programs to Hold Workshop on Evidence-Based Treatment for Dual Diagnoses

Venice Beach, Calif. (PRWEB) June 04, 2013

On Friday, June 14, 2013, Clearview Treatment Programs will present “Integrative Treatment for Dual Diagnoses: Evidence-Based Treatments That Work,” in Venice Beach, Calif.

The clinical workshop will provide participants practical knowledge of Motivational Interviewing, Acceptance and Commitment Therapy (ACT), and Cognitive Behavioral Therapy (CBT):

  • Motivational Interviewing is a goal-oriented form of treatment that is designed to help with ambivalence, motivation, and change, and can be highly effective in dual diagnosis treatment. Motivational Interviewing includes a series of four stages: pre-contemplative, contemplative, preparation and action, followed by the maintenance stage.
  • Acceptance and Commitment Therapy (ACT) is a therapy that uses mindfulness and acceptance strategies to build psychological flexibility. One of the core tenets of ACT is accepting one’s painful emotions, and to develop a new set of values to help overcome the negativity they experience in life. ACT is very effective with clients who suffer from addictions and dual diagnosis.
  • Cognitive Behavioral Therapy (CBT) helps clients address their dysfunctional thinking and behavior that perpetuate problems with mental health and substance abuse disorders. It examines problematic symptoms that are persistent because the clients need skills to challenge their underlying irrational thinking about how they view themselves, others, and the world.

“These evidence-based treatments have proven to be extremely effective when it comes to treating dual diagnosis,” said Michael Roy, LCSW, MSW, executive director of Clearview Treatment Programs, a premier dual diagnosis treatment center in Los Angeles. “This workshop provides a concise overview of how they can work for therapists who treat that population.”

Featured speakers at the workshop will be Chelsea Cawood, Ph.D., therapist at Clearview Women’s Center for Borderline Personality Disorder; Matt Swank, MSW, LCSW, therapist at Clearview Center for Psychiatric Disorders and Addictions; and Nicole Zaha, Psy.D., therapist at Clearview Women’s Center.

The workshop will be held from 8:30 a.m. to 12:30 p.m. at Clearview Center in Venice Beach. Admission to the workshop is $35, which includes a light breakfast. The clinical workshop is offering 3.5 continuing education units for MFTs and LCSWs.

Register here for this clinical workshop.

About Clearview Treatment Programs

Clearview Treatment Programs in Venice Beach, Calif., is a premier provider of mental health and addiction treatment. Clearview provides highly individualized treatment programs for people with psychiatric disorders, alcohol and drug addictions, and dual diagnosis.

Clearview Treatment Programs, started in 2000, operates multiple treatment centers in the Southern California beach communities and the Los Angeles area. Clearview offers a full continuum of care, including residential treatment, day treatment, outpatient treatment, and transitional living treatment centers in Los Angeles.

For more information, please visit

About Clearview Women’s Center

Clearview Women's Center for Borderline Personality and Emotional Disorders offers residential, day treatment, and outpatient comprehensive Dialectical Behavior Therapy (DBT) programs. Our programs are designed to treat women who struggle with emotional dysregulation, relational conflicts, impulse control, and/or self-harmful behaviors.

For more information, please visit our website

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DBT Expert Charles Swenson to Present at Upcoming Clearview Workshop
2. Clearview Treatment Programs Clinical Director to Present on DBT and Substance Abuse at WCSAD
3. Scientist awarded $1 million grant to develop tools for hepatitis C treatment discovery
4. Clinical insight improves treatment with new lung cancer drug
5. Rapid Asthma Treatment in ER May Prevent Admission
6. Novel compound demonstrates anti-leukemic effect in zebrafish, shows promise for human treatment
7. Breast cancer patients suffer treatment-related side effects long after completing care
8. Mayo Clinic offers newly approved treatment for acid reflux disease
9. Mobile Stroke Units Might Trim Time to Treatment
10. Breast Cancer Treatment Side Effects May Last for Years
11. Mouse Study Hints at New Path for Diabetes Treatment
Post Your Comments:
(Date:11/26/2015)... ... November 26, 2015 , ... WorldCare International, Inc., ... the 61st annual Employee Benefits Conference. The Employee Benefits Conference was hosted by ... through Wednesday, November 11th, 2015. The conference was held at the Hawaii Convention ...
(Date:11/26/2015)... ... November 26, 2015 , ... Indosoft Inc., developer and distributor of ... server to improve system efficiency and reliability. , The new Q-Suite 6 platform is ... the system avoids locking itself into a specific piece of software for many key ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... preparing the perfect dish and pleasing the palates of attendees is of the ... a dish to a seasonal get-together, give these recipes a try this holiday ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... offering factory direct sauna parts and accessories. , Sauna accessories help improve the ... bather’s style and personality. From basic styles for the purist looking for simplicity ...
(Date:11/25/2015)... ... ... On November 10, 2015, Bohrer Brady, LLC filed a class and collective ... home health care worker who provided companionship services for the elderly, ill or disabled ... Humana, Inc., Humana at Home, Inc., and SeniorBridge Family Companies (CT), Inc. since January ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... 2015  Amgen (NASDAQ: AMGN ) today announced ... the United States (U.S.) Food ... candidate to Humira ® (adalimumab). Amgen believes this ... the FDA and represents Amgen,s first BLA submission using ... , M.D., executive vice president of Research and Development ...
(Date:11/25/2015)... -- On Tuesday, November 24, 2015, the jury ... Medical Technology, Inc. for product liability and misrepresentation ... device, awarded $11 million in favor of Plaintiff ... three days of deliberations, the jury found that ... and unreasonably dangerous, and that Wright Medical made ...
(Date:11/25/2015)... Nov. 25, 2015 Allergan plc (NYSE: AGN ... the New York State Attorney General,s ... Sherman Act, and other statutes with the Attorney General over ... to cease marketing and selling the now generic version of ... admits no liability, has released its counterclaims against ...
Breaking Medicine Technology: